Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes
出版年份 2021 全文链接
标题
Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes
作者
关键词
-
出版物
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 54, Issue 7, Pages 952-966
出版商
Wiley
发表日期
2021-08-16
DOI
10.1111/apt.16543
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
- (2020) Helen Jarvis et al. PLOS MEDICINE
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD
- (2019) Mary E. Rinella et al. HEPATOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- The effect of uncertainty in patient classification on diagnostic performance estimations
- (2019) Leo C. McHugh et al. PLoS One
- Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes
- (2019) Fernando Bril et al. DIABETES CARE
- Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
- (2019) Thierry Poynard et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease
- (2019) Fabio Nascimbeni et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Impact of steatosis and inflammation definitions on the performance of NASH tests
- (2018) Thierry Poynard et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference
- (2018) Thierry Poynard et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
- (2018) Thierry Poynard et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
- (2018) Fernando Bril et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- Back to Byzance: Querelles byzantines over NASH and fibrosis
- (2017) Vlad Ratziu JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
- (2016) M. Munteanu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Critical comparison of elastography methods to assess chronic liver disease
- (2016) Mireen Friedrich-Rust et al. Nature Reviews Gastroenterology & Hepatology
- Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B
- (2015) M. Houot et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards
- (2015) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- Liver fibrosis evaluation using real-time shear wave elastography: Applicability and diagnostic performance using methods without a gold standard
- (2013) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age
- (2011) Thierry Poynard et al. BMC GASTROENTEROLOGY
- Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard
- (2011) Thierry Poynard et al. JOURNAL OF HEPATOLOGY
- Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
- (2011) Shan Liu et al. PLoS One
- Diagnosis and Classification of Diabetes Mellitus
- (2009) DIABETES CARE
- How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve Revisited
- (2008) J. Lambert et al. CLINICAL CHEMISTRY
- Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease
- (2008) Raj Vuppalanchi et al. Clinical Gastroenterology and Hepatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now